VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (4768)	1/19/1998 11:23:00 AM
From: EyeDrMike	Read Replies (1) of 23519

<<<"-All of PFE's major products have patent protection beyond the year 2001 and can not be legally substituted. Moreover, not many physicians are not willing to prescribe less expensive older drugs for the newer products" "-During the last 10 years, the largest yearly PFE decline was 14% ( in 1992 with the election of President Clinton). The possibility of a 30% PFE decline given its new products and strong investor support would require a huge market retreat that would effect every stock including VVUS.">>> The street values a company not on what it has done, but what it most likely will do. The year 2001 is just around the corner, and if patents are expiring and the threat to PFE earnings appears, you can bet that the stock price will be punished. PFE has moved last 12 months largely because of Viagra anticipation, If Viagra doesn't become the wonder drug to PFE's bottom line, you'll likely see this 30% decline in share price or more. In regards to what physicians will most likely prescribe, in many settings today, the doctor only has a specific formulary from which to choose. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next